Eli Lilly’s shares up as oral GLP-1RA scores in first Phase III trial
Lilly plans to submit orforglipron for approval in weight management by the end of 2025, with a type 2 diabetes application to follow in 2026.
Cullinan Therapeutics receives EMA approval for rheumatoid arthritis drug trial
Northwestern University enrols first subject in trial of drug for pericarditis
Sabin Vaccine Institute begins trial of vaccine candidate for Marburg virus disease
WHO warns that polio cases are on the rise
Glycomine raises $115m to advance rare disease therapy into Phase IIb
Analysis
View More
Themes
View MoreIoT can help to reduce the burden of clinical trials on patients
IoT helps to decentralise clinical trials, allowing them to become increasingly patient-centric and diverse while providing pharmaceutical companies with a higher return on investment.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
1 of 2
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Mastering compliance and copyright in healthcare and MedComms
MWC Barcelona 2025: Maximizing 5G network value in the age of AI
Driving bioscience innovation: How Teesside University empowers industry breakthroughs
The AI advantage in discovering new medicines